​How a patent law tweak may add $1.3 billion in drug costs – CBS News

The pharmaceutical industry wants to bypass a legal process, which the CBO says will hit taxpayers

Sourced through Scoop.it from: www.cbsnews.com

Unknown's avatar

Kenneth Carnesi holds a Juris Doctor degree from New York Law School and a Professional Certificate in International Banking from Harvard Law School. Kenneth Carnesi is the Director of Operations and Government Sales at Anaptyx LLC and sits on the Boards of The Lazarus Organization, Monkeetech LLC and MG Madison Phillips, Inc. Mr. Carnesi has also founded CICG - Carnesi International Consulting Group, a company specializing in strategy consulting to small to mid-size businesses.

Posted in Uncategorized

Leave a comment